AbbVie Inc. (ABBV) will go ex-dividend on October 15, 2025, with shareholders of record set to receive a $1.64 per share dividend payable on November 14, 2025. This event is significant as ex-dividend dates often influence short-term stock price movements, with shares typically adjusting downward by the dividend amount on the ex-date. The stock closed at $229.18 on October 14, 2025, reflecting a modest decline of 0.49% ahead of the ex-dividend date, and traded at $229.49 (+0.14%) after hours. No other major company-specific news or announcements were reported for AbbVie on October 14, 2025, and the price action aligns with typical ex-dividend dynamics rather than broader market moves.
AbbVie Set for $1.64 Dividend Payout; Ex-Dividend Date October 15, 2025
ABBV
Related News
ABBV
AbbVie Nears $10.9 Billion Apogee Deal, Strengthening Immunology Pipeline
ABBV
AbbVie Unveils Venclexta and Epcoritamab Data, Bolstering Oncology Market Position
ABBV
🟢 AbbVie Inc. shares rise 3.6% after its cancer drug Elahere wins NHS approval in England
ABBV
🟢 AbbVie Inc. is trading 3% up today as shares extend a multi-day rebound amid a rotation into defensive healthcare
ABBV